Christian Lood, PhD
University of Washington
Seattle, WA, United States
Disclosure(s): Amytryx: Grant/Research Support (Terminated, August 1, 2023); Boehringer Ingelheim: Grant/Research Support (Ongoing); Citryll: Consultant (Ongoing); Eli Lilly: Grant/Research Support (Terminated, April 1, 2023); Exagen: Consultant (Ongoing); Gilead Sciences: Grant/Research Support (Terminated, December 31, 2023); Pfizer: Grant/Research Support (Terminated, December 31, 2023); Redd Pharma: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)
Richard Moore, BSc (he/him/his)
Cedars-Sinai
Beverly Hills, CA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Christian Lood, PhD
University of Washington
Seattle, WA, United States
Disclosure(s): Amytryx: Grant/Research Support (Terminated, August 1, 2023); Boehringer Ingelheim: Grant/Research Support (Ongoing); Citryll: Consultant (Ongoing); Eli Lilly: Grant/Research Support (Terminated, April 1, 2023); Exagen: Consultant (Ongoing); Gilead Sciences: Grant/Research Support (Terminated, December 31, 2023); Pfizer: Grant/Research Support (Terminated, December 31, 2023); Redd Pharma: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)
Mitochondria have emerged as much more than energy-providing organelles, being implicated also in regulation of cell death, inflammation, and oxidative stress. In this session, we will highlight recent findings where mitochondria promote inflammation and autoimmunity in rheumatic disease.
Speaker: J. Michelle Kahlenberg, MD, PhD – University of Michigan
Speaker: Simone Caielli, PhD – weill cornell medicine